Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06902935

Establishment and Clinical Application of Breast Cancer Risk Prediction Model Based on Traditional Chinese Medicine Four Diagnostic Instruments and Ultrasound

Status
Not Yet Recruiting
Phase
Study type
Observational
Enrollment
1,500 (estimated)
Sponsor
Taizhou Hospital · Academic / Other
Sex
Female
Age
30 Years – 75 Years
Healthy volunteers
Not accepted

Summary

Construct a breast cancer risk prediction model based on traditional Chinese medicine four diagnostic instruments and B-ultrasound images. Ensure that the key evaluation indicators of the model reach a high level through clinical verification, so as to contribute to accurate clinical diagnosis and treatment decision-making.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTDiagnosis of Breast Cancer by Traditional Chinese Medicine Four ExaminationsThe Daosheng TCM Four-Diagnostic Instrument (DS01-A) comprehensively collects patients' TCM four-diagnostic information, covering tongue (e.g., overall color, coating color/thickness/greasiness, tooth marks, etc.), pulse (e.g., position, force, rhythm, etc.), face (e.g., overall color, luster, lip color/dryness, etc.) and constitution scores (quantifying 9 constitutions via the TCM Constitution Classification Table).
DIAGNOSTIC_TESTUltrasound diagnosis of breast cancerProfessional ultrasound physicians use B - ultrasound equipment of the same model to accurately collect detailed parameters of breast masses according to a standardized process. These parameters include shape (oval, round, irregular), orientation (parallel, non - parallel), margin (smooth, non - smooth, with non - smooth including blurred, angular, microlobulated, spiculated, etc.), echo pattern (anechoic, hyperechoic, complex cystic - solid echo, hypoechoic, isoechoic, heterogeneous echo), posterior echo characteristics (no change, enhancement, shadowing, mixed), calcification (microcalcification and coarse calcification within the mass, calcification outside the mass, intraductal), and vascular supply (no blood supply, internal blood supply, marginal blood supply), etc.

Timeline

Start date
2025-04-26
Primary completion
2027-04-26
Completion
2027-04-26
First posted
2025-03-30
Last updated
2025-03-30

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06902935. Inclusion in this directory is not an endorsement.